188 related articles for article (PubMed ID: 33376727)
21. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
22. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
23. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
24. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
[TBL] [Abstract][Full Text] [Related]
25. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Wu B; Tao L; Yang D; Li W; Xu H; He Q
Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
[TBL] [Abstract][Full Text] [Related]
26. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
27. A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
[TBL] [Abstract][Full Text] [Related]
28. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
29. CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer.
Han J; Zhang X; Liu Y; Jing L; Liu YB; Feng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32797167
[TBL] [Abstract][Full Text] [Related]
30. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Zheng Q; Min S; Zhou Q
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
[TBL] [Abstract][Full Text] [Related]
32. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
34. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
[TBL] [Abstract][Full Text] [Related]
35. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
[TBL] [Abstract][Full Text] [Related]
37. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
[TBL] [Abstract][Full Text] [Related]
38. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
39. Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
Hossain MJ; Chowdhury UN; Islam MB; Uddin S; Ahmed MB; Quinn JMW; Moni MA
Comput Biol Med; 2021 Aug; 135():104539. PubMed ID: 34153790
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
Jiang H; Dong L; Gong F; Gu Y; Zhang H; Fan D; Sun Z
Int J Mol Med; 2018 Jul; 42(1):368-380. PubMed ID: 29693170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
